The last few time Nader as spoke, he did mention BO. On the proactive video when talking about the shared drive the 2 examples he gave were for licensing or buyout, not partnership. Then again on the Dr. Been interview.
Maybe we won't get a buyout but sell off individual indications? Sell Covid, sell HIV. Those would be more realistic numbers, and the reason we now have 3 labels? Vyrologix, Immuvance, and Leronlimab?
News 
Market Data 
Discover 
